Hyperprolactinemia in systemic lupus erythematosus? 1996

B Ostendorf, and R Fischer, and R Santen, and B Schmitz-Linneweber, and C Specker, and M Schneider
Center of Rheumatology, Heinrich-Heine-University of Düsseldorf, Germany.

The objective of this project was to determine the prevalence of hyperprolactinemia (HPRL) in systemic lupus erythematosus (SLE) and to evaluate the role of prolactin (PRL) as a disease-activity marker. We determined PRL in a cohort of 182 patients with SLE. Basal prolactin levels and clinical data (disease-activity index, sero-activity, medications) were analyzed in all patients. The findings show only mildly elevated PRL levels in four SLE-patients and normaprolactinemia in 98% (n = 178), without any association with disease activity. Our results differ from previous studies. HPRL appears not to be prevalent in SLE, nor to be associated with disease activity.

UI MeSH Term Description Entries
D006966 Hyperprolactinemia Increased levels of PROLACTIN in the BLOOD, which may be associated with AMENORRHEA and GALACTORRHEA. Relatively common etiologies include PROLACTINOMA, medication effect, KIDNEY FAILURE, granulomatous diseases of the PITUITARY GLAND, and disorders which interfere with the hypothalamic inhibition of prolactin release. Ectopic (non-pituitary) production of prolactin may also occur. (From Joynt, Clinical Neurology, 1992, Ch36, pp77-8) Prolactin Hypersecretion Syndrome,Prolactin, Inappropriate Secretion,Hyperprolactinaemia,Inappropriate Prolactin Secretion,Inappropriate Prolactin Secretion Syndrome,Hyperprolactinemias,Hypersecretion Syndrome, Prolactin,Inappropriate Secretion Prolactin,Prolactin Secretion, Inappropriate,Secretion Prolactin, Inappropriate,Secretion, Inappropriate Prolactin,Syndrome, Prolactin Hypersecretion
D008180 Lupus Erythematosus, Systemic A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow. Libman-Sacks Disease,Lupus Erythematosus Disseminatus,Systemic Lupus Erythematosus,Disease, Libman-Sacks,Libman Sacks Disease
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011388 Prolactin A lactogenic hormone secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). It is a polypeptide of approximately 23 kD. Besides its major action on lactation, in some species prolactin exerts effects on reproduction, maternal behavior, fat metabolism, immunomodulation and osmoregulation. Prolactin receptors are present in the mammary gland, hypothalamus, liver, ovary, testis, and prostate. Lactogenic Hormone, Pituitary,Mammotropic Hormone, Pituitary,Mammotropin,PRL (Prolactin),Hormone, Pituitary Lactogenic,Hormone, Pituitary Mammotropic,Pituitary Lactogenic Hormone,Pituitary Mammotropic Hormone
D001799 Blood Sedimentation Measurement of rate of settling of ERYTHROCYTES in blood. Erythrocyte Sedimentation,Erythrocyte Sedimentation Rate,Erythrocyte Sedimentation Rates,Rate, Erythrocyte Sedimentation,Rates, Erythrocyte Sedimentation,Sedimentation Rate, Erythrocyte,Sedimentation Rates, Erythrocyte,Sedimentation, Blood,Sedimentation, Erythrocyte
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

B Ostendorf, and R Fischer, and R Santen, and B Schmitz-Linneweber, and C Specker, and M Schneider
January 1997, Zhonghua yi xue za zhi = Chinese medical journal; Free China ed,
B Ostendorf, and R Fischer, and R Santen, and B Schmitz-Linneweber, and C Specker, and M Schneider
December 1998, The Journal of rheumatology,
B Ostendorf, and R Fischer, and R Santen, and B Schmitz-Linneweber, and C Specker, and M Schneider
April 1992, The American journal of the medical sciences,
B Ostendorf, and R Fischer, and R Santen, and B Schmitz-Linneweber, and C Specker, and M Schneider
June 1999, Annals of the New York Academy of Sciences,
B Ostendorf, and R Fischer, and R Santen, and B Schmitz-Linneweber, and C Specker, and M Schneider
January 2010, Clinical and experimental rheumatology,
B Ostendorf, and R Fischer, and R Santen, and B Schmitz-Linneweber, and C Specker, and M Schneider
January 1998, Lupus,
B Ostendorf, and R Fischer, and R Santen, and B Schmitz-Linneweber, and C Specker, and M Schneider
June 2004, La Tunisie medicale,
B Ostendorf, and R Fischer, and R Santen, and B Schmitz-Linneweber, and C Specker, and M Schneider
May 1998, Ginecologia y obstetricia de Mexico,
B Ostendorf, and R Fischer, and R Santen, and B Schmitz-Linneweber, and C Specker, and M Schneider
January 2005, Archives of medical research,
B Ostendorf, and R Fischer, and R Santen, and B Schmitz-Linneweber, and C Specker, and M Schneider
November 2008, Oral and maxillofacial surgery clinics of North America,
Copied contents to your clipboard!